Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pyrrolo[1,2- B ][1,2,5] benzodiazepines (PBTDs) Compounds Induce Apoptosis in Chronic Myeloid Leukaemia Cells from Patients at Onset, Imatinib and Second Generation TK Inhibitors (Dasatinib, Nilotinib) Resistant.

Elisabetta Abruzzese, MD, Gabriella Marfe’, PhD, Carla Di Stefano, MD, Malgorzata M. Trawinska, MD, Matteo A. Russo, MD, Romano Silvestri, PhD, Giovanni Del Poeta, MD, Giovanni Martinelli, MD, Simona Soverini, PhD, Paolo de Fabritiis, MD, Sergio Amadori, MD, Paola Sinibaldi Salimei, PhD

Blood (2006) 108 (11): 1385.

https://doi.org/10.1182/blood.V108.11.1385.1385

Published: 2006

Journal Articles

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Nicoletta Testoni, PhD, Alfonso Zaccaria, MD, Franca Radaelli, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Federica Sora’, MD, Monica Crugnola, MD, Michele Cedrone, MD, Gianantonio Rosti, MD, Sergio Amadori, MD, Paolo de Fabritiis, MD, Michele Baccarani, MD

Blood (2006) 108 (11): 2116.

https://doi.org/10.1182/blood.V108.11.2116.2116

Published: 2006

Journal Articles

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial.

Monica Bocchia, MD, Elisabetta Abruzzese, MD, Micaela Ippoliti, PhD, Maria Teresa Pirrotta, MD, Malgorzata M. Trawinska, MD, Marilina Amabile, PhD, Giovanni Martinelli, MD, Francesco Forconi, MD, Alessandro Gozzetti, MD, Angelo M. Carella, MD, Donatella Raspadori, PhD, Francesco Lauria, MD

Blood (2005) 106 (11): 167.

https://doi.org/10.1182/blood.V106.11.167.167

Published: 2005

Journal Articles

Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in Cell Lines and in 12 Chronic Myeloid Leukemia Patients at Onset and Imatinib-Resistant.

Carla Di Stefano, MD, Elisabetta Abruzzese, MD, Gabriella Marfe, BS, Romano Silvestri, Pharmacy, Gianfranco Catalano, MD, Malgorzata M. Trawinska, MD, Paola Sinibaldi-Salimei, MD, Sergio Amadori, MD

Blood (2004) 104 (11): 4692.

https://doi.org/10.1182/blood.V104.11.4692.4692

Published: 2004

Journal Articles

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Alfonso Zaccaria, MD, Nicoletta Testoni, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Tommaso Caravita, MD, Paola Panetta, BS, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Franca Radaelli, MD, Federica Sora’, MD, Gianantonio Rosti, Sergio Amadori, MD, Michele Baccarani, MD

Blood (2004) 104 (11): 2936.

https://doi.org/10.1182/blood.V104.11.2936.2936

Published: 2004

NARROW

Pyrrolo[1,2- B ][1,2,5] benzodiazepines (PBTDs) Compounds Induce Apoptosis in Chronic Myeloid Leukaemia Cells from Patients at Onset, Imatinib and Second Generation TK Inhibitors (Dasatinib, Nilotinib) Resistant.

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial.

Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in Cell Lines and in 12 Chronic Myeloid Leukemia Patients at Onset and Imatinib-Resistant.

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Email alerts

ASH Publications

American Society of Hematology

Pyrrolo[1,2- B ][1,2,5] benzodiazepines (PBTDs) Compounds Induce Apoptosis in Chronic Myeloid Leukaemia Cells from Patients at Onset, Imatinib and Second Generation TK Inhibitors (Dasatinib, Nilotinib) Resistant.

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial.

Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in Cell Lines and in 12 Chronic Myeloid Leukemia Patients at Onset and Imatinib-Resistant.

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only